Untitled

Abstract

Staphylococcus aureus is a pathogen notoriously known for its ability to resist antibiotics. Here, we reported the activity of the sea hare Aplysia dactylomela ink L-AAO protein, dactylomelin-P, against 100 clinical isolates of multiple antibiotic-resistance S. aureus with a prevalence of 30% methicillin-resistant (MRSA). Dactylomelin-P was able to inhibit the growth of all isolates with inhibition zones average size of 17.90 ± 2.58 mm. Among the eleven commercial antibiotics tested, only vancomycin, quinupristin/dalfopristin and linezolid exhibited similar efficiency. These findings highlight the potential of dactylomelin-P against S. aureus and MRSA as well as support further research with dactylomelin-P as an antibacterial drug candidate.